Finance

Lists
Why is MANE down ४.१३%?
Dive Deeper
MANE:NYSE
Veradermics Inc
US$ ११०.३२
-४.१३%
(-४.७५) 1D
अक्टोबर १६, १०:३७:५९ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MANE...
Open
US$ ११४.१९
High
US$ ११४.२५
Low
US$ १०९.०२
Mkt. cap
४.६१ अरब
Avg. vol.
८.४३ लाख
Volume
८८.५२ हजार
52-wk high
US$ १३६.७२
52-wk low
US$ ३२.००
EPS
-US$ ३.३५
No. of employees
३७
Open
US$ ११४.१९
High
US$ ११४.२५
Low
US$ १०९.०२
Mkt. cap
४.६१ अरब
Avg. vol.
८.४३ लाख
Volume
८८.५२ हजार
52-wk high
US$ १३६.७२
52-wk low
US$ ३२.००
EPS
-US$ ३.३५
No. of employees
३७
News stories
From web sources and news partners
About Veradermics Inc
CEO-
Employees३७
Founded२०१९
Headquartersन्यू हेवन, कनेक्टिकट, संयुक्त राज्य अमेरिका
Sector-
Websiteveradermics.com
Analyst ratings
Based on 4 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current US$ ११०.३२
US$ १८२.०० (+६४.९७%)
Average
US$ १६९.०० (+५३.१९%)
Lowest
US$ १६०.०० (+४५.०३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
US$ १६०.००
+४५%
10/15/2026
Roger Song
Jefferies
Buy
Maintained
US$ १८२.००
+६५%
09/08/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ १८२.००
+६५%
09/08/2026
Serge Belanger
Needham
Buy
Maintained
US$ १६४.००
+४८.७%
08/12/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
US$ १७०.००
+५४.१%
08/11/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
US$ १७०.००
+५४.१%
07/15/2026
Marc Goodman
Leerink Partners
Buy
Initiated
US$ ७५.००
-३२%
03/02/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
03/01/2026
Last report
२०२६ अगस्ट ११
Fiscal period
Q2 2026
-US$ ०.५८ / -US$ ०.६४
+९.५६%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.४३ करोड
१.८२ करोड
२.०९ करोड
१.८६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१७.४४ लाख
४८.१९ लाख
८९.३७ लाख
१.०९ करोड
Operating expense
१.६१ करोड
२.३० करोड
२.९९ करोड
२.९६ करोड
Total operating expenses
१.६१ करोड
२.३० करोड
२.९९ करोड
२.९६ करोड
Operating income
-१.६१ करोड
-२.३० करोड
-२.९९ करोड
-२.९६ करोड
Other non operating income
३.२५ लाख
२.५८ लाख
१.४९ लाख
१२.१३ लाख
EBT including unusual items
-१.५६ करोड
-२.१८ करोड
-२.७२ करोड
-२.३५ करोड
EBT excluding unusual items
-१.५६ करोड
-२.१८ करोड
-२.७२ करोड
-२.३५ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.५६ करोड
-२.१८ करोड
-२.७२ करोड
-२.३५ करोड
Net profit margin
-
-
-
-
Earnings per share
-
-१०४.५४
-१.३२
-०.५८
Interest and investment income
१.०३ लाख
९.०६ लाख
२४.८१ लाख
४८.३८ लाख
Interest expense
-
-
-
-
Net interest expenses
१.०३ लाख
९.०६ लाख
२४.८१ लाख
४८.३८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू